Hi andrew,
here is the posting from daytrade:
************************
Pej,
To give you a medical spin on this play. There has been alot of buzz
going
on lately with the artificial blood r&d. SMTG and a couple of other
companies are on the forefront and very close to completing phase iii
trials for an iminent product approval by FDA.
Something is up with this one. I smell news coming soon. It could be
that it is riding the coat-tails of Biotime who recently completed their
phase 3 trials. The products are similar and so its likely their trials
wont be too far behind. These two companies will likely be the first to
have an artificial blood product on the market and will capture billions
of dollars per year in revenue from it.
Needless to say, I am defintely playing this one.
Tony
Pejman Hamidi wrote:
>
> SMTG performed beautifully today and managed to close above key resistance
> of 8 1/6. The volume was relatively high, and today's action created buy
> signal on STOCH & MACD. Acc/Swing shows symmetrical breakout, Acc/Dist
> shows downtrend distribution line penetration, and volatility is rising
> from low levels. This one is giving me the same feel as UIS did, and as
> SYQT is doing now as well. The target is 9 3/4. Will re-establish either
> lower, if breakout above 10 occurs. If not, we will be able to pick her
> back up at lower levels. If 8 1/16 holds in the morning, it will most
> likely hold throughout the day, therefore, I will again be adding to my
> positions.
>
> Pejman
>
> _______________
> Submitted by "Pejman Hamidi" <pejman@worldnet.att.net>
> Remember: Caveat emptor. Do your own homework. Web: pobox.com
> To unsubscribe: Send "unsubscribe daytrades" to majordomo@pobox.com
_______________
Submitted by Tony White <whitet@airnet.net>
Remember: Caveat emptor. Do your own homework. Web: pobox.com
To unsubscribe: Send "unsubscribe daytrades" to majordomo@pobox.com |
